• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of novel therapeutic strategies targeting BMP9 that contributes to the acquisition of malignant properties in hepatocellular carcinoma

Research Project

Project/Area Number 18K15807
Research Category

Grant-in-Aid for Early-Career Scientists

Allocation TypeMulti-year Fund
Review Section Basic Section 53010:Gastroenterology-related
Research InstitutionKanazawa University

Principal Investigator

Nio Kouki  金沢大学, 附属病院, 助教 (80807397)

Project Period (FY) 2018-04-01 – 2021-03-31
Project Status Completed (Fiscal Year 2020)
Budget Amount *help
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2019: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2018: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Keywords肝細胞癌 / がん幹細胞 / BMP9 / ID1 / BMP受容体阻害剤 / 癌幹細胞 / バイオマーカー / 血管新生 / CD105
Outline of Final Research Achievements

In this study, we aimed to elucidate the role of BMP9 signaling in cancer stem cell (CSC) properties of hepatocellular carcinoma (HCC) and to assess the therapeutic effect of BMP receptor inhibitors in HCC. We have first identified that high BMP9 expression in serum from patients with HCC leads to poorer outcome. BMP9 promoted CSC properties in EpCAM-positive HCC subtype via enhancing ID1 expression in vitro. Additionally, ID1 knockdown significantly repressed BMP9-promoted HCC-CSC properties by suppressing Wnt/β-catenin signaling. Cells treated with BMP receptor inhibitors K02288 and LDN-212854 blocked HCC-CSC activation by inhibiting BMP9-ID1 signaling. Treatment with LDN-212854 suppressed HCC tumor growth by repressing ID1 and EpCAM in vivo. Our study demonstrates the pivotal role of BMP9-ID1 signaling in promoting HCC-CSC properties and the therapeutic potential of BMP receptor inhibitors in treating EpCAM-positive HCC.

Academic Significance and Societal Importance of the Research Achievements

再発や転移、薬物療法抵抗性の源と考えられているがん幹細胞は、進行肝細胞癌において重要な治療標的と考えられている。今回我々は、BMP9シグナル(細胞情報伝達)による肝がん幹細胞活性化のメカニズムを解明し、BMP9シグナルを阻害するBMP受容体阻害剤が肝細胞癌における有望な治療法となる可能性を示した。今後、高悪性度(腫瘍が大きくなる速度が速い、腫瘍マーカーが高値)や難治性(薬物療法が効きにくい)の進行肝細胞癌に対する臨床応用が期待される。本研究結果は、国内および海外の学術集会での報告と英文誌掲載により広く社会・国民に発信した。

Report

(4 results)
  • 2020 Annual Research Report   Final Research Report ( PDF )
  • 2019 Research-status Report
  • 2018 Research-status Report
  • Research Products

    (9 results)

All 2021 2020 2019 2018

All Journal Article (1 results) (of which Peer Reviewed: 1 results,  Open Access: 1 results) Presentation (8 results) (of which Int'l Joint Research: 2 results)

  • [Journal Article] BMP9‐ID1 signaling promotes EpCAM‐positive cancer stem cell properties in hepatocellular carcinoma2021

    • Author(s)
      Chen Han、Nio Kouki、Yamashita Taro、Okada Hikari、Li Ru、Suda Tsuyoshi、Li Yingyi、Doan Phuong Thi Bich、Seki Akihiro et.al
    • Journal Title

      Molecular Oncology

      Volume: not available Issue: 8 Pages: 2203-2218

    • DOI

      10.1002/1878-0261.12963

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access
  • [Presentation] 肝癌幹細胞の活性化に寄与するID1を標的とした治療法の検討2021

    • Author(s)
      丹尾 幸樹、山下 太郎、金子 周一
    • Organizer
      第107回日本消化器病学会総会
    • Related Report
      2020 Annual Research Report
  • [Presentation] BMP9 promotes EpCAM-positive cancer stem cell properties in hepatocellular carcinoma via ID1 activation.2020

    • Author(s)
      Kouki Nio, Taro Yamashita, Han Chen, Hikari Okada, Masao Honda, Shuichi Kaneko
    • Organizer
      AASLD 2020
    • Related Report
      2020 Annual Research Report
    • Int'l Joint Research
  • [Presentation] 幹細胞性肝細胞癌に対するBMP9シグナル阻害剤の治療効果検討2020

    • Author(s)
      丹尾 幸樹、山下 太郎、金子 周一
    • Organizer
      第56回日本肝臓学会総会
    • Related Report
      2020 Annual Research Report
  • [Presentation] Targeting BMP9-ID1 signaling suppresses cancer stem cell features in hepatocellular carcinoma.2020

    • Author(s)
      Han Chen, Kouki Nio, Taro Yamashita, Hikari Okada, Masao Honda, Shuichi Kaneko
    • Organizer
      58th JSCO
    • Related Report
      2020 Annual Research Report
    • Int'l Joint Research
  • [Presentation] 肝細胞癌悪性形質に関わるBMP9分子シグナルが制御する癌幹細胞維持機構の検討2019

    • Author(s)
      丹尾 幸樹、山下 太郎、本多 政夫、金子 周一
    • Organizer
      第55回日本肝臓学会総会
    • Related Report
      2019 Research-status Report
  • [Presentation] Clinical and biological significance of BMP9 in the malignant nature of hepatocellular carcinoma2019

    • Author(s)
      Kouki Nio, Taro Yamashita, Shuichi Kaneko
    • Organizer
      JDDW2019
    • Related Report
      2019 Research-status Report
  • [Presentation] 肝細胞癌悪性形質に関わるBMP9分子シグナルが制御する癌幹細胞維持機構の検討2019

    • Author(s)
      丹尾 幸樹、山下 太郎、本多 政夫,金子 周一
    • Organizer
      第55回日本肝臓学会総会
    • Related Report
      2018 Research-status Report
  • [Presentation] 肝細胞癌におけるBMP9発現の臨床的意義と幹細胞性維持への影響2018

    • Author(s)
      丹尾 幸樹,陳 晗,山下 太郎,金子 周一
    • Organizer
      第54回日本肝癌研究会
    • Related Report
      2018 Research-status Report

URL: 

Published: 2018-04-23   Modified: 2022-01-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi